PubMed Health⌕ Search

Biomedical subjects

M Sadowski

Publications and source records attributed to M Sadowski.

23 records · Page 2Linked to original sources

The second layer neurones of the entorhinal cortex and the perforant path in physiological ageing and Alzheimer's disease.

The hippocampal formation was studied in 5 brains of younger (29 to 52 years of age) and 6 brains of elderly (61 to 89 years of age) subjects without signs of dementia, as well as in 11 brains of patients with Alzheimer's disease (65 to 91 years of age). The 8-microns-thick sections were stained either with cresyl violet, Weil method or with immunocytochemical methods for amyloid (4G8) and neurofibrillary tangles (Tau-1). Cell bodies, senile plaques and tangles were counted in all brains. In brains of patients with Alzheimer's disease a significant neuronal loss (about 56%) was observed in the second layer of the entorhinal cortex. The tangles/neurones ratio was very high (62.79.1%) in this layer. A great number of senile plaques were present in the whole hippocampal formation, especially in the molecular layer of the dentate gyrus (22.91.5 plaques/mm2) which is the termination zone of the perforant path. It seems therefore, that pathological alterations in Alzheimer's disease disrupt the main input to the hippocampal formation. In "physiological" ageing we did not observe changes in the density of neurones, although single tangles and plaques were found in all hippocampal areas. In elderly individuals 3.81.3% of neurones of the second layer revealed neurofibrillary pathology; a few plaques were found in various areas of the hippocampal formation. These observations may suggest only a slight decrease in number of neurones in the hippocampal formation. However, these changes cause a slight impairment of memory and learning often found in elderly individuals without dementia.

Adult↗

Cytoarchitectonics of the nucleus of the lateral olfactory tract in the rat.

The cytoarchitectonics of the nucleus of the lateral olfactory tract (NLOT) was studied on Nissl stained sections in 6 brains of adult Wistar rats by using morphometric methods. The neuronal density of layer III (11,866 +/- 547 mm-3) is on average about three times smaller than that of layer II (30,947 +/- 1110 mm-3). The average cross-section area of neurons in layer III (254.3 +/- 3.8 microns2) is about twice as large as that of neurons in layer II (115.8 +/- 0.8 microns2). The layer II is rather homogenous in contrast to layer III which possesses neurons of various size. Other morphometric parameters of layer II and III are also different.

Animals↗

Investigations on the synthesis and pharmacological properties of amides of 7-methyl-3-phenyl-1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-2,4- dioxo-1,2,3,4-tetrahydropyrido[2,3-d]-pyrimidine-5-carboxylic acid.

Synthesis of amides of 7-methyl-3-phenyl-2,4-dioxo-1,2,3,4- tetrahydropyrido[2,3-d]pyrimidine-5-carboxylic acid (6-10) and their 1-[2-hydroxy-3(4-phenyl-1-piperazinyl)propyl] derivatives (11-15) are described. Some of them displayed strong analgesic activity.

Amides↗

Variations of EGF-R surface expression in squamous cell carcinomas of the head and neck region.

BACKGROUND: It has been previously found that the epidermal growth factor receptor (EGF-R) is highly expressed in squamous cell carcinomas of the head and neck region (SCCHN) and that this expression correlates with malignant transformation and tumor development. MATERIALS AND METHODS: We examined 9 SCCHN cell lines and a control keratinocyte cell line for EGF-R expression, utilizing fluorescence-activated cell sorting (FACS) and Western blot analysis. Immuno-cytochemistry was performed to evaluate the receptor's cellular distribution. RESULTS: We found the EGF-R to be up-regulated in SCCHN. Surprisingly we did not see a clear correlation between tumor staging, grading or Stat3 signaling and EGF-R level but we observed up to three distinct EGF-R specific bands in our Western blots, implicating the presence of different protein isoforms. CONCLUSION: Our data suggest that not only the amount but also the receptor function, including the presence of mutations, need to be considered in SCCHN malignancies.

Carcinoma, Squamous Cell↗